- Home
- ANTX vs ANEB Comparison
ANTX vs ANEB Comparison
Compare ANTX & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- ANEB
- Stock Information
- Founded
- ANTX 2017
- ANEB 2020
- Country
- ANTX United States
- ANEB United States
- Employees
- ANTX N/A
- ANEB N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- ANTX Health Care
- ANEB Health Care
- Exchange
- ANTX Nasdaq
- ANEB Nasdaq
- Market Cap
- ANTX 37.6M
- ANEB 36.7M
- IPO Year
- ANTX 2022
- ANEB 2021
- Fundamental
- Price
- ANTX $1.12
- ANEB $1.53
- Analyst Decision
- ANTX Hold
- ANEB Buy
- Analyst Count
- ANTX 5
- ANEB 1
- Target Price
- ANTX $3.50
- ANEB $8.00
- AVG Volume (30 Days)
- ANTX 110.0K
- ANEB 13.9K
- Earning Date
- ANTX 03-27-2025
- ANEB 02-11-2025
- Dividend Yield
- ANTX N/A
- ANEB N/A
- EPS Growth
- ANTX N/A
- ANEB N/A
- EPS
- ANTX N/A
- ANEB N/A
- Revenue
- ANTX N/A
- ANEB N/A
- Revenue This Year
- ANTX N/A
- ANEB N/A
- Revenue Next Year
- ANTX N/A
- ANEB N/A
- P/E Ratio
- ANTX N/A
- ANEB N/A
- Revenue Growth
- ANTX N/A
- ANEB N/A
- 52 Week Low
- ANTX $0.87
- ANEB $0.80
- 52 Week High
- ANTX $21.40
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- ANTX 31.57
- ANEB 52.82
- Support Level
- ANTX $1.09
- ANEB $1.39
- Resistance Level
- ANTX $1.14
- ANEB $1.70
- Average True Range (ATR)
- ANTX 0.04
- ANEB 0.13
- MACD
- ANTX -0.01
- ANEB -0.00
- Stochastic Oscillator
- ANTX 10.00
- ANEB 60.00
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.